TOXIC-SHOCK-SYNDROME
Prevalence of Toxic Shock Syndrome Toxin 1 Producing Staphylococcus aureus and the Presence of Antibodies to This Superantigen in Menstruating Women
... Menstrual toxic shock syndrome (mTSS) is thought to be associated with colonization with toxic shock syndrome toxin 1 (TSST-1)-producing Staphylococcus aureus in women with ...
7
Detection of New Methicillin Resistant Staphylococcus aureus Clones Containing the Toxic Shock Syndrome Toxin 1 Gene Responsible for Hospital and Community Acquired Infections in France
... the toxic shock syndrome toxin gene (tst), exfoliative toxin genes (eta and etb), PVL genes (lukS-PV-lukF-PV), the LukE- lukD leukocidin genes (lukE-lukD), the class F lukM leukocidin gene (lukM), ...
8
Streptococcus pyogenes bacteremia and toxic shock syndrome related to Strongyloides stercoralis hyperinfection: a case report
... We present a case of S. stercoralis hyperinfection associ- ated with GAS bacteremia. This case is unusual in several aspects: (1) the association between GAS bacteremia and S. stercoralis hyperinfection has not been ...
6
Oxygen and Carbon Dioxide Regulation of Toxic Shock Syndrome Toxin 1 Production by Staphylococcus aureus MN8
... staphylococcal toxic shock syndrome (TSS) and is considered to be the cause of nearly all cases of menstrual TSS and at least 50% of nonmenstrual cases ...desquamating syndrome, which affects ...
7
Successful treatment of out of hospital cardiopulmonary arrest due to streptococcal toxic shock syndrome – effectiveness of extracorporeal membrane oxygenation and the rapid antigen group A streptococcus test: a case report
... Streptococcal toxic shock syndrome (STSS) caused by Streptococcus pyogenes, a group A streptococcus (GAS), infection is an uncommon but serious illness that rapidly progresses to multiple organ ...
5
Toxin Profiling of Staphylococcus aureus Strains Involved in Varicella Superinfection
... The most common complications of varicella are bacterial skin and soft tissue infections, generally due to Staphylococcus aureus and group A beta-hemolytic streptococci. The aim of this study was to characterize the ...
5
Persistence survey of Toxic Shock Syndrome toxin 1 producing Staphylococcus aureusand serum antibodies to this superantigen in five groups of menstruating women
... Serum IgG levels against TSST-1 has also been found to be higher in persistent carriers than in non-carriers of S. aureus [42]. From these findings, it appears that antibody titers in women found to be colonized with ...
8
Epidermal HLA DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis
... purified toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxin type B, and streptococcal pyrogenic enterotoxin types A and C to induce inflammatory reactions in clinically uninvolved skin ...
10
Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome
... tively) that caused streptococcal toxic shock syndrome (STSS) were collected and characterized. Eleven strains were identified as Streptococcus dysgalactiae subsp. equisimilis, and one strain was ...
7
Induction of human interleukin 1 by a product of Staphylococcus aureus associated with toxic shock syndrome
... with toxic shock syndrome elaborate material that induces human blood monocytes to secrete interleukin-1 ...from toxic shock syndrome (TSS)-associated strains cause biphasic ...
10
Epidemiologic Analysis of Invasive and Noninvasive Group A Streptococcal Isolates in Hong Kong
... The M protein is an important virulence determinant in the pathogenesis of both suppurative and nonsuppurative diseases due to group A streptococci (GAS). Approximately 150 differ- ent M protein gene sequence types have ...
6
The effect of Staphylococcus aureus carriage in late pregnancy on antibody levels to staphylococcal toxins in cord blood and breast milk
... and toxic shock syndrome toxin-1 (TSST-1), in cord blood and breast milk and also explored the relationship between levels of antibody in antenatal serum and cord ...
8
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report
... days 8, 4, and 8, respectively. Soon erythema developed, and desquamation occurred 2 weeks after disease onset. In addition, isolated MSSA strains produced toxic shock syndrome toxin-1 (TSST-1). ...
5
Surviving streptococcal toxic shock syndrome: a case report
... Streptococcal toxic shock syndrome is a distinct entity, which is aggressive compared to the milder forms of strep- tococcal infections such as pyomyositis and fasciitis ...
6
RS3PE syndrome developing during the course of probable toxic shock syndrome: a case report
... suspected toxic shock syndrome ...RS3PE syndrome, for which he satisfied all four diagnostic criteria: 1) pitting edema in the limbs, 2) acute onset, 3) age ≥ 50 years, and 4) rheumatoid ...
7
Severe Drug Eruption in Guinea Conakry
... in Toxic Epidermal Necrolysis (TEN) and the Stevens-Johnson syndrome (SJS) and 5% - 10% in the Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) ...
6
Necrotizing fasciitis caused bySerratia marcescens after tooth extraction in a Doberman Pinscher: a case report
... Treatment of NF requires antimicrobial therapy, surgical debridement and delayed reconstruction (Naidoo et al., 2005). When there are concurrent signs of shock, aggressive supportive treatment is needed, i.e. ...
7
Major Outbreak of Toxic Shock Like Syndrome Caused by Streptococcus mitis
... Severe illness caused by viridans streptococci rarely occurs in immunocompetent hosts. Between December 1990 and May 1991, thousands of patients in the YangZi River Delta area of Jiangsu Province, China, suffered from ...
5
Streptococcus suis Related Prosthetic Joint Infection and Streptococcal Toxic Shock Like Syndrome in a Pig Farmer in the United States
... Septicemia and meningitis are among the most common clinical pre- sentations (10), with an associated mortality of 2.6 to 18% (9). During an outbreak of S. suis infection in humans in China, 28% of patients presented ...
5